Delivery Order SPE2DE21D0005-SPE2D625F1249

Award Date 10/7/24
Potential Completion Date 10/10/24
Potential Value $6.8K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency Troop Support Medical has awarded Organogenesis Inc., a leading regenerative medicine company, a $1,118.88 fixed-price delivery order contract to provide PURAPLY AM (2x2) 4 sq cm wound dressings. This order is part of Organogenesis' existing $49.5 million multiple-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency for wound care dressings, discs, and medical materials that runs through May 2026. Organogenesis is also a preeminent supplier of...
This federal contract award is a delivery order (SPE2DE21D0005|SPE2D625F212L) valued at $5,100.00, issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The award is for the supply of PURAPLY AM XT 4.91X4.91, an advanced wound care product. Organogenesis is a leading provider of regenerative medicine solutions to federal healthcare agencies, particularly the Department of Defense (DoD) and Department...
This federal contract award to Organogenesis Inc. is a $2,200.00 fixed-price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical for the product PURAPLY AM XT 4.91X4.91. The award has an ultimate completion date of July 5, 2024 and does not utilize a set-aside designation. Organogenesis Inc. is a leading regenerative medicine company that has been awarded numerous contracts with the Department of Defense (DoD) and Department of Veterans Affairs (VA) to supply...
This federal contract award, valued at $6,800.00, was issued by the Defense Logistics Agency (DLA) to Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts. The contract, which does not have a set-aside designation, is a Delivery Order for PURAPLY AM XT 4.91X4.91 medical supplies. Organogenesis is a key supplier of advanced wound care, surgical biologics, and tissue regeneration products to federal healthcare agencies, particularly the Department of...
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, worth $49.5 million, for wound care dressings and medical supplies. Organogenesis, headquartered in Canton, Massachusetts, specializes in advanced wound care, surgical biologics, and tissue...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The contract, valued at $4,645.00, is for the supply of PURAPLY MZ 500MG, a regenerative wound care product. Organogenesis is a for-profit organization and a manufacturer of goods. The contract does not utilize any set-aside designations. This delivery order is part of a larger $49.5 million multiple-award Indefinite Delivery...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The $8,800.00 contract is for the supply of PURAPLY AM XT wound care dressings. This order is part of a larger $183.15 million Multiple Award Indefinite Delivery Contract (IDC) issued by the DLA for medical and surgical supplies under the Medical/Surgical ECAT Program. Organogenesis also holds other significant IDVs with the...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,118.88 fixed-price delivery order with economic price adjustment to Organogenesis Inc., a leading regenerative medicine company based in Canton, Massachusetts. The order is for PURAPLY AM (2x2) 4 SQ CM, an advanced wound care product. This order is part of Organogenesis' broader federal contract vehicles, including a $49.5 million multiple-award Indefinite Delivery Contract with DLA Troop Support Medical for wound care...
This is a $1,118.88 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading manufacturer of regenerative medicine products. The order is for PURAPLY AM wound care dressings, which are advanced skin substitutes used to support tissue repair and regeneration. Organogenesis is an experienced federal contractor, holding several significant Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA...
The U.S. government has awarded a $2,200.00 fixed-price delivery order contract to Organogenesis Inc., a leading regenerative medicine company, for the supply of PURAPLY AM XT 4.91x4.91 medical products. This contract was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and does not utilize a set-aside designation. Organogenesis Inc. is an experienced federal contractor, supplying a wide range of wound care and surgical biologics to the Department of...
  • SPE2DE21D0005
    Indefinite Delivery Contract
  • SPE2DE21D0005-SPE2D625F1249
    Delivery Order

This federal contract award, valued at $6,800.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The award is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, which has a total ceiling value of $49.5 million for wound care dressings, discs, and medical materials. The contract does not have a set-aside designation.

The specific product being procured is PURAPLY AM XT, an advanced wound care dressing manufactured by Organogenesis. The company has a strong track record of providing innovative regenerative medicine solutions to the Department of Defense (DoD) and Department of Veterans Affairs (VA), supporting the medical needs of military personnel and veterans. Organogenesis also holds several other significant IDVs with the VA, including a $25 million IDC for next-generation surgical implants and a $30 million Federal Supply Schedule contract for tissue regeneration products.

Generated 1/6/25, 12:22 PM